CSI Market
Sign In | Register

Recursion Pharmaceuticals Inc (RXRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RXRX Annual Balance Sheets →
The balance sheet data below highlights changes in Recursion Pharmaceuticals Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent545.68
Cash & Short-term Investments545.00
Other Receivables, Net, Current14.39
Other Current Assets34.71
Prepaid Expense, Current AS8.68
Total Current Assets603.46
Equipment/Property/Plant Net89.62
Goodwill net160.35
Intangible Assets282.89
Other Assets, Noncurrent76.35
Restricted Cash Current5.51
Restricted Cash Noncurrent5.20
Operating Lease Right Of Use Asset42.82
Total Assets1,212.67
Liabilities
Accounts Payable, Current AC12.67
Accrued Liabilities, Current AC56.94
Long-term Debt and Capital Lease Obligations, Current DE9.44
Other Liabilities, Current35.37
Taxes Payable3.56
Deferred Liability and Revenue1.91
Total Current Liabilities119.89
Long-term debt4.75
Total Long-term Debt4.75
Other liabilities, Noncurrent173.03
Contract With Customer Liability Current32.79
Contract With Customer Liability Noncurrent114.72
Total Liabilities297.67
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock3,211.52
Retained Earnings / Accumulated Deficit-2,324.51
Accumulated Other Comprehensive Income27.99
Other Equity27.99
Common Stockholder's Equity915.00
Total Stockholder's Equity915.00
Liabilities & Stockholder's Equity1,212.67
4 historic quarters locked

Sign in to unlock the full Recursion Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Recursion Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001601830-26-000098

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.